UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
UBS Maintains a 'Neutral' on Seattle Genetics (SGEN); What We Learned from the 1Q11 Call
-
UBS Maintains a 'Neutral' on Seattle Genetics (SGEN); Updating Model for 4Q10 Results
-
UBS Maintains a 'Neutral' on Seattle Genetics (SGEN); Strong Results in Hodgkin Lymphoma
-
UBS Maintains a 'Neutral' on Seattle Genetics (SGEN); Lintuzumab Development Discontinued
-
Notable Analyst Rating Changes 08/31: GPS, ANF, BMY, UBS Upgraded; HPQ, DGIT, RAX, POT Downgraded
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
Seattle Genetics (SGEN) Prices 5.74M Share Public Offering
-
Notable Analyst Rating Changes 6/19: AIG, KMX, TOT Upgraded; KFT, AGU, UBS, CVH Downgraded
-
UBS Initiates Coverage on Seattle Genetics (SGEN) with a Neutral
-
Notable Analyst Rating Changes 1/28: CAT, MRK, K, GIS, FCX Upgraded; WAG, FUL, MTL Downgraded
